NO308074B1 - FremgangsmÕte for racemisering av optiske anrikete heterocykliske karboksanilider - Google Patents

FremgangsmÕte for racemisering av optiske anrikete heterocykliske karboksanilider

Info

Publication number
NO308074B1
NO308074B1 NO971358A NO971358A NO308074B1 NO 308074 B1 NO308074 B1 NO 308074B1 NO 971358 A NO971358 A NO 971358A NO 971358 A NO971358 A NO 971358A NO 308074 B1 NO308074 B1 NO 308074B1
Authority
NO
Norway
Prior art keywords
pct
compound
carboxanilides
racemization
date
Prior art date
Application number
NO971358A
Other languages
English (en)
Norwegian (no)
Other versions
NO971358L (no
NO971358D0 (no
Inventor
Ulrich Conrad Dyer
Christopher James Lock
Martin Woods
Original Assignee
Darwin Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9504927.6A external-priority patent/GB9504927D0/en
Application filed by Darwin Discovery Ltd filed Critical Darwin Discovery Ltd
Publication of NO971358L publication Critical patent/NO971358L/no
Publication of NO971358D0 publication Critical patent/NO971358D0/no
Publication of NO308074B1 publication Critical patent/NO308074B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B53/00—Asymmetric syntheses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B55/00—Racemisation; Complete or partial inversion

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Measurement Of Radiation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO971358A 1994-09-23 1997-03-21 FremgangsmÕte for racemisering av optiske anrikete heterocykliske karboksanilider NO308074B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP94306962 1994-09-23
GBGB9504927.6A GB9504927D0 (en) 1995-03-10 1995-03-10 Racemisation and asymmetric transformation
PCT/GB1995/002247 WO1996009290A1 (en) 1994-09-23 1995-09-22 Racemisation and asymmetric transformation processes used in the manufacture of levobupivacaine and analogues thereof

Publications (3)

Publication Number Publication Date
NO971358L NO971358L (no) 1997-03-21
NO971358D0 NO971358D0 (no) 1997-03-21
NO308074B1 true NO308074B1 (no) 2000-07-17

Family

ID=26137306

Family Applications (1)

Application Number Title Priority Date Filing Date
NO971358A NO308074B1 (no) 1994-09-23 1997-03-21 FremgangsmÕte for racemisering av optiske anrikete heterocykliske karboksanilider

Country Status (18)

Country Link
US (1) US5786484A (pt)
EP (1) EP0782569B1 (pt)
JP (1) JP3898220B2 (pt)
KR (1) KR100393133B1 (pt)
CN (1) CN1104416C (pt)
AT (1) ATE214695T1 (pt)
AU (1) AU695479B2 (pt)
CA (1) CA2200490C (pt)
DE (1) DE69525950T2 (pt)
DK (1) DK0782569T3 (pt)
ES (1) ES2173194T3 (pt)
FI (1) FI117436B (pt)
HU (1) HU216291B (pt)
MX (1) MX9702210A (pt)
NO (1) NO308074B1 (pt)
PL (1) PL183204B1 (pt)
PT (1) PT782569E (pt)
WO (1) WO1996009290A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6384227B2 (en) 1995-01-18 2002-05-07 Darwin Discovery Ltd. Racemisation process for use in the manufacture of levobupivacaine and related piperidinecarboxanilide anaesthetic agents
JP2000256359A (ja) * 1999-03-11 2000-09-19 Japan Science & Technology Corp 面性キラリティーを有する分子群の高選択的不斉変換法
US6288280B1 (en) * 1999-07-09 2001-09-11 Hoffmann-La Roche Inc. Racemization of atropisomeric bis(phosphine oxide) compounds
BR0002246A (pt) 2000-04-06 2003-04-15 Cristalia Prod Quimicos Farm Processo de obtenção dos enantiÈmeros da bupivacaìna racêmica, processo de obtenção de composições farmacêuticas a base de levobupivacaìna: composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis e utilização das composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis
US6962998B2 (en) 2000-06-14 2005-11-08 Toray Industries, Inc. Processes for producing racemic piperidine derivative and for producing optically active piperidine derivative
DE10029851A1 (de) * 2000-06-16 2001-12-20 Boehringer Ingelheim Pharma Enantiomerentrennung von Piperidon-Derivaten unter gleichzeitiger in situ Racemisierung des unerwünschten Enantiomers
US6495694B2 (en) 2000-06-16 2002-12-17 Boehringer Ingelheim Pharma Kg Efficient separation of enantiomers of piperidone derivatives by precipitation of the desired eantiomer during in situ racemization of the unwanted enantiomer
BRPI0104491B8 (pt) * 2001-10-10 2021-05-25 Cristalia Produtos Quim Farmaceuticos Ltda n-(2,6-dimetilfenil)-1-propil-2-piperidinocarboxamida; processo de obtenção dos enantiômeros; mistura não racêmica dos anantiômeros e seu processo de obtenção e composição farmacêutica.
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
EP2218448B1 (en) 2002-12-13 2015-09-23 Durect Corporation Oral drug delivery system comprising high viscosity liquid carrier materials
CA2581287C (en) * 2004-09-17 2015-08-25 Durect Corporation Sustained local anesthetic composition containing bupivacaine and saib
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
AU2007325918B2 (en) 2006-11-03 2013-10-17 Durect Corporation Transdermal delivery systems comprising bupivacaine
JP2011506319A (ja) 2007-12-06 2011-03-03 デュレクト コーポレーション 疼痛、関節炎症状、または慢性疾患に伴う炎症の治療に有用な方法
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
CN102093284B (zh) * 2010-12-29 2013-05-08 宜昌人福药业有限责任公司 富集哌啶-2-甲酰苯胺类旋光化合物的方法
AU2014233453A1 (en) 2013-03-15 2015-10-01 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
CN103664744B (zh) * 2013-11-30 2015-07-15 山东永泰化工有限公司 一种左布比卡因的制备方法
CA3100706A1 (en) * 2018-05-18 2019-11-21 Kura Oncology, Inc. Synthesis of tipifarnib
BR112022013784A2 (pt) 2020-01-13 2022-10-11 Durect Corp Sistemas de distribuição de fármacos de liberação prolongada com impurezas reduzidas e métodos relacionados

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE451840B (sv) * 1986-01-03 1987-11-02 Astra Laekemedel Ab Optiskt rent monohydrat av s-(-)-1-propyl-2',6'-pipekoloxylididhydroklorid, sett att framstella denna och farmaceutiska beredningar for lokalbedovning

Also Published As

Publication number Publication date
PL183204B1 (pl) 2002-06-28
DE69525950D1 (de) 2002-04-25
FI117436B (fi) 2006-10-13
AU3527995A (en) 1996-04-09
ES2173194T3 (es) 2002-10-16
PT782569E (pt) 2002-09-30
JP3898220B2 (ja) 2007-03-28
DE69525950T2 (de) 2002-09-19
US5786484A (en) 1998-07-28
NO971358L (no) 1997-03-21
EP0782569B1 (en) 2002-03-20
PL319368A1 (en) 1997-08-04
DK0782569T3 (da) 2002-07-22
CN1104416C (zh) 2003-04-02
AU695479B2 (en) 1998-08-13
NO971358D0 (no) 1997-03-21
KR100393133B1 (ko) 2003-11-17
ATE214695T1 (de) 2002-04-15
CA2200490C (en) 2007-01-09
WO1996009290A1 (en) 1996-03-28
CA2200490A1 (en) 1996-03-28
FI971202A (fi) 1997-03-21
JPH10505855A (ja) 1998-06-09
FI971202A0 (fi) 1997-03-21
HU216291B (hu) 1999-06-28
MX9702210A (es) 1998-05-31
HUT77055A (hu) 1998-03-02
CN1159184A (zh) 1997-09-10
EP0782569A1 (en) 1997-07-09

Similar Documents

Publication Publication Date Title
NO308074B1 (no) FremgangsmÕte for racemisering av optiske anrikete heterocykliske karboksanilider
DE59607490D1 (de) Verfahren zur herstellung von wirkstoffzubereitungen in form einer festen lösung des wirkstoffs in einer polymermatrix
DE69527617D1 (de) Verfahren zur racematspaltung von etodolac unter verwendung von glucamin-derivaten
DE69531624D1 (de) Verfahren zur herstellung von levobupivacaine und analoge
ATE182879T1 (de) Neuartig substituierte dtpa-derivate, deren metallkomplexe, diese komplexe enthaltende pharmazeutische mittel, deren verwendung in der diagnostik und therapie, sowie verfahren zur herstellung der komplexe und mittel
DE69523038T2 (de) Verfahren zur herstellung von hiv proteasinhibitoren
ATE224871T1 (de) Verfahren zur herstellung von enantiomerenreinen azetdin-2-carbonsäuren
DE69717076T2 (de) Verfahren zur herstellung von galanthanin
DE69713163T2 (de) Verfahren zur herstellung von enantiomerisch angereicherten n-acylazetidin-2-carbonsäuren
ATE216702T1 (de) Silylierungsprocess
ATE370242T1 (de) Verfahren zur herstellung von dipeptiden
DE59604613D1 (de) Verfahren zur herstellung von optisch aktiven alpha-aminosäuren und alpha-aminosäure-derivaten
DE69519388D1 (de) Verfahren zur herstellung von 2-(omega-alkoxycarbonylalkanoyl)-4-butanolid und langkettiger omega-hydroxycarbonsäure
ATE288901T1 (de) Verfahren zur herstellung von 5-hydroxymethyl-2- oxazolidinon und neues zwischenprodukt
DK0808306T3 (da) Hidtil ukendte pyridin- eller pyridazinderivater, fremgangsmåder til fremstilling deraf og lægemidler indeholdende disse fo
DE59808082D1 (de) Verfahren zur herstellung von langkettigen glycin-n,n-diessigsäure-derivaten
DE3769442D1 (de) Neues verfahren zur herstellung von optisch aktiven carbacyclin-zwischenprodukten.
DK0784603T3 (da) Racemisering af forstadier for levobupivacain og analoge forstadier heraf
ATE282028T1 (de) Verfahren zur kontinuierlichen herstellung von basischen, cyclischen, optisch aktiven alpha- aminosäuren

Legal Events

Date Code Title Description
MK1K Patent expired